Overall rank by patents
#37,231
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Research ranks #37,231 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R37231 · US Corporation #37,231 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: RepliCel Life Sciences Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Research Intertional · this assignee
29 score
3D Lighting… · lowest
7 score
What this shows Research's Innovation Score is 28.9/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Research Intertional, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2017. By volume, Research sits between RepliCel Life Sciences Inc. and Rhode Island Hospital, A Lifespan-Partner.
Research Intertional, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
RepliCel Life Sciences Inc.
7 patents
Research Electronics International, LLC
7 patents
Research Institute for Electromagnetic Materials
7 patents
Research Instruments Corporation
7 patents
Revieve Oy
7 patents
Rheinkalk GmbH
7 patents
Rhodan Marine Systems of Florida, LLC
7 patents
Rhode Island Hospital, A Lifespan-Partner
7 patents
Research Intertional, Inc.
7 patents
What this shows Research holds 7 patents at rank #37,240, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #37,240 in granted patent volume.
Other assignees with the most granted patents in Research's primary technology class.
Research's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 29th percentile higher than 29% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 14.3% |
| 2019 | 2 | 28.6% |
| 2020 | 1 | 14.3% |
| 2021 | 1 | 14.3% |
| 2024 | 2 | 28.6% |
Top 6 of 6 technology areas
Overall rank by patents
#37,231
of 49,997 tracked assignees
28.9 out of 100
What to do with this data
Research Intertional, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.